ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FoxWayne, Aerami Therapeutics SPAC Deal Said Worth $195 Million firstwordpharma
August 16, 2021According to people familiar with the matter, Aerami Therapeutics is holding talks with blank-check firm FoxWayne Enterprises about a potential merger that could value the combined company at about $195 million, reported Bloomberg.
Pharma Sources Insight January 2025
